Blog - Page 1976 of 5721

ThursdayJul 11, 2019 12:09 pm

Geyser Brands Inc. (TSX.V: GYSR) Strengthens Leadership with Key Appointments

Seasoned life sciences executive Dr. Bin Huang has been appointed to the Geyser board of directors Chartered Professional Account Gordon Clissold has been named chief executive officer Geyser Brands is entering into a definitive agreement for the acquisition of Solace Management Group, which will broaden the company’s range of CBD- and hemp-based products Geyser Brands Inc. (TSX.V: GYSR), a leading consumer health care company based in Vancouver, British Columbia, builds health-based hemp CBD consumer products in the worldwide nutraceutical, cosmetics, food & beverage and pet sectors. Recent pivotal appointments to Geyser Brand’s leadership team are expected to strengthen the company’s…

ThursdayJul 11, 2019 11:33 am

Willow Biosciences Inc. (CSE: WLLW) Developing Biosynthesis Platform for Production of Low-Cost, Pharmaceutical-Grade CBD

A joint development agreement signed with Noramco Inc., the world’s largest producer of chemically synthesized cannabinoids and pharmaceutical APIs, is expected to scale the development of Willow’s CBD biosynthesis program The collective market for CBD sales in the U.S. is expected to exceed $20 billion by 2024, while the cannabinoid-based pharmaceuticals market may reach $50 billion by 2029 Synthetic biology is expected to disrupt the cannabinoid industry supply chain, providing access to new and larger markets for CBD and related compounds Willow Biosciences Inc. (CSE: WLLW), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (APIs)…

ThursdayJul 11, 2019 11:02 am

QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) Developing Key Resource Portfolio as Lithium Demand Rises

Lithium demand is seen as being long-term and relentless This market dynamic creates favorable conditions for resource development companies like QMC Quantum Minerals QMC is already at work to initiate sustainable lithium production at its Irgon Lithium Mine Project Global lithium demand is anticipated to triple by 2025, driven primarily by expanded lithium-ion battery production for the electric vehicle market. According to a lithium market update, demand for lithium grew by more than 27 percent in 2018 (http://ibn.fm/9fsZn) and is expected to grow at rates above 20 percent in 2019. Forecasts suggest that lithium demand will continue growing at healthy levels…

ThursdayJul 11, 2019 10:39 am

QualityStocksNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) Announces Cannabis Biopesticide R&D Program with National Research Council Canada

MustGrow Biologics (CSE: MGRO), an agricultural biotech company, this morning announced that a biopesticide R&D program is underway with the National Research Council Canada (“NRC”). According to the update, the R&D team is conducting a series of efficacy assessments of MustGrow’s patented biopesticide as a natural pre-plant, pre-pot soil treatment for diseases and pests that affect cannabis production. MustGrow intends to seek approval of its natural biopesticide from Health Canada for eventual use by Canada’s licensed cannabis producers. Currently, the R&D program is targeting a number of soil-borne pests and diseases that have been particularly problematic for many of Canada’s…

ThursdayJul 11, 2019 10:29 am

Growth of Organic Farming Providing Opportunities for Natural Biopesticide Companies Like MustGrow Biologics Corp. (CSE: MGRO)

Organic farming is forecast to grow at a CAGR of 8.4 percent through 2026, fueled by high demand and concerns about the use of traditional agricultural practices The organic pesticide market is also expected to expand, at a CAGR of approximately 14.9 percent through 2023 These market dynamics show that companies like MustGrow Biologics that specialize in biopesticides and biofertilizers could benefit from significant growth opportunities As the global organic farming market continues growing at a sustainable and consistent rate, new expansion opportunities emerge for organizations such as MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company that develops and…

ThursdayJul 11, 2019 10:27 am

QualityStocksNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Partners with American Eagle Outfitters, Inc. (NYSE: AEO) to Provide Specialty Line of CBD-Infused Personal Care Products

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced its receipt of a purchase order from American Eagle Outfitters, Inc. (NYSE: AEO), through which it will sell hemp-derived cannabidiol (“CBD”) infused personal care products in nearly 500 American Eagle stores and online. According to the update, the purchase order represents GGB's third major wholesale agreement since passage of the 2018 Farm Bill. Sales of the products exclusively developed for American Eagle, including a wide assortment of CBD-infused personal care items such as lotions, muscle balms and aromatherapy, are expected to begin in October 2019. “We are very…

ThursdayJul 11, 2019 9:39 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTC: LXRP) DehydraTECH to be Leveraged Through CBD License Agreement with Universal Hemp

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to Universal Hemp LLC. Under the agreement, Universal Hemp, a B2B manufacturer of high-performing hemp-derived bulk ingredients to the consumer packaged goods and nutraceutical industries, will utilize the technology in many CBD-based food ingredients to be produced and sold across the U.S. immediately, as well as in Canada when regulations permit. “We are very excited about signing this licensing agreement with Lexaria Bioscience to bring to…

ThursdayJul 11, 2019 9:30 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Subsidiary to Conduct Five Day Trial of Cellular-Based Accident Prevention Solution

Automotive technology innovator Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., will conduct a large-scale trial of its Eye-Net(TM) cellular-based accident prevention solution for the first time. The five-day trial is set to take place in Israel from July 24th until July 29th, 2019. The trial represents a key milestone for Eye-Net as it evolves from technology to product. Thousands of users are anticipated to participate in the trial, which is open to the general public and is limited to the first 30,000 enrolled participants. A trade-in company of leading car…

WednesdayJul 10, 2019 3:47 pm

QualityStocksNewsBreaks – Hemptown USA Enters Consumer Packaged Goods Space through Kirkman Group Acquisition

Hemptown USA, a privately held company headquartered in Southern Oregon’s Emerald Triangle, today announced the acquisition of all assets of Kirkman Group, a Lake Oswego, Oregon-based FDA licensed, current good manufacturing practice (“cGMP”) certified nutraceutical business. The acquisition includes the entirety of the management team, production equipment, formulations, proprietary intellectual property, current sales channels and fulfillment centers. This transaction also marks the company’s immediate entry into the consumer packaged goods space. “The Kirkman Group is a key strategic acquisition for Hemptown. Being fully operational and FDA licensed accelerates Hemptown’s vertical integrations plans. Kirkman’s high quality formulations and production standards will…

Site Search

Company Search